Northwestern Mutual Wealth Management
ARNA

Northwestern Mutual Wealth Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-733
Closed -$68K – 3548
2021
Q4 		$68K Buy
+733
New +$48.3K ﹤0.01% 1869
2021
Q3 		– Sell
-137
Closed -$9K – 3327
2021
Q2 		$9K Buy
+137
New +$8.93K ﹤0.01% 2489
2019
Q4 		– Sell
-600
Closed -$27K – 2704
2019
Q3 		$27K Buy
+600
New +$33.7K ﹤0.01% 1631
2017
Q3 		– Sell
-25
Closed – – 2314
2017
Q2 		$0 Buy
+25
New +$343 ﹤0.01% 2209

Northwestern Mutual Wealth Management's ARNA Position: Q1 2022 in Review

Northwestern Mutual Wealth Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 733 shares — an estimated $68K sold.

Northwestern Mutual Wealth Management first reported a position in ARNA in Q2 2017 and held it in 4 quarters. The position peaked at $68K in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Northwestern Mutual Wealth Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 733 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $68K.
  • Northwestern Mutual Wealth Management first reported a position in Arena Pharmaceuticals Inc in Q2 2017 and held it in 4 quarters.
  • Northwestern Mutual Wealth Management's Arena Pharmaceuticals Inc position peaked at $68K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2022, filed 9 May 2022.